Table 1.
Demographic characteristics and clinical features of OSCC patients.
| Variables | OSCC (n = 392) |
|---|---|
| Age (years) | 55.33 ± 10.93 |
| Gender: male (%) | 385 (98.2%) |
| Smoking status | |
| No | 46 (11.7%) |
| Yes | 346 (88.3%) |
| Drinking status | |
| No | 190 (48.5%) |
| Yes | 202 (51.5%) |
| Betel nuts chewing | |
| No | 85 (21.7%) |
| Yes | 307 (78.3%) |
| EGFL6 (pg/mL) | 304.48 ± 194.55 |
| Stage | |
| I | 103 (26.3%) |
| II | 67 (17.1%) |
| III | 42 (10.7%) |
| IV | 180 (45.9%) |
| Tumor T status | |
| T1 | 124 (31.6%) |
| T2 | 109 (27.8%) |
| T3 | 33 (8.4%) |
| T4 | 126 (32.1%) |
| Lymph node status | |
| N0 | 253 (64.5%) |
| N1 | 46 (11.7%) |
| N2 | 90 (23.0%) |
| N3 | 3 (0.8%) |
| Metastasis | |
| M0 | 390 (99.5%) |
| M1 | 2 (0.5%) |
| Cell differentiation | |
| Well differentiated | 57 (14.5%) |
| Moderately or poorly differentiated | 335 (85.2%) |